Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


Izon Science secures investment for expansion

Izon Science secures investment for expansion

Christchurch, NZ and Oxford, UK, 20 February 2014 – Izon Science (www.izon.com), a global leader in accurate nanoparticle analysis, today announced it has completed a £1 million (NZ$2.0m) funding round in the UK.

In conjunction with the investment, Izon’s global headquarters are being transferred from Christchurch to the Oxford Science Park, UK where an Izon subsidiary has been operating since 2010. Hans van der Voorn, Izon’s Executive Chairman is now based there.

Izon is also appointing two UK-based board members: Alex Hambro, who is also non-executive chairman of AIM-listed Judges Scientific plc, and Mark Rowan, who is also a non-executive director of AIM-listed Imperial Innovations Group plc. Izon is itself expecting to list on AIM in due course.

Izon has also appointed Stephen Dawson as its CFO, based in Oxford. Stephen has an undergraduate science degree and is a Chartered Accountant with extensive experience in CFO and CEO roles in large and emerging UK based exporting companies.

“The establishment of the corporate headquarters in the UK allows us better access to European and North American markets and reflects the reality of a more favourable capital raising environment in the UK for global science companies,” says van der Voorn.

The company plans to double the size of its UK team this year to support the move. Manufacturing and R&D will continue in Christchurch, where staff numbers are being boosted in line with the company’s overall expansion plans.

“The increased capital and market access enabled by the move to Oxford has allowed us to take on more staff in order to expand the product portfolio and to increase business with our key suppliers in Christchurch,” adds Van der Voorn.

Izon’s patented technology, Tunable Resistive Pulse Sensing (TRPS), offers the most accurate series of nano and microparticle analyses for advanced biomedical applications. Nanomedicine development, extracellular vesicles and viruses are all important and growing areas of interest.

Fine-scale control and monitoring of the forces acting on particles as they pass through a nanopore allows the size, count and charge of particle samples to be probed with higher resolution and accuracy than other technologies. The detailed nanoscale measurements are also generating new tools for quantifiable bio-analysis.

The company has developed three instruments that it currently sells into life science research and product development markets:
• the qNano, Izon’s flagship product for nano- and micro-particle measurement;
• the qViro-X, dedicated for virus and vaccine analysis; and
• the qMicro, designed for analysis of cellular samples and injectable drugs.

Van der Voorn says that Izon’s strengthened European presence will also allow it to focus on collaborations that accelerate product development and application development. “The sensitive detection capabilities of TRPS are just beginning to be exploited. We work closely with our customers to solve their analysis problems and that typically leads to the generation of new ideas.”

To further support its expansion, Izon is planning to open offices in China, Germany and India. The company is also opening a second US office in San Diego, CA to add to its facility in Cambridge, MA which has been operating since 2011.

About Izon Science:
Izon Science designs and manufactures precision instrumentation for nano- and micro-scale particle analysis. Izon originated in New Zealand and now sells its products in 36 countries. Izon’s global headquarters are located in Oxford, UK. The company also has a US headquarters in Cambridge, MA, and an R&D and manufacturing facility in Christchurch, NZ.http://www.izon.com

ENDS

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Scoop Business: RBNZ Starts Talks On Tougher Rules For Property Speculators

The Reserve Bank of New Zealand is stepping up preparations to restrict lending to residential property investors as it watches house prices, particularly in Auckland, continue to rise strongly. More>>

ALSO:

Research: ‘Ageing Well’ Science Challenge Launched

Science and Innovation Minister Steven Joyce today launched the Ageing Well National Science Challenge, confirming initial funding of $14.6 million. More>>

ALSO:

Scoop Business: Govt Resisting Pressure To Pump More Cash Into Solid Energy

Prime Minister John Key says it is “not the government’s preferred option” to make a fresh capital injection into the troubled state-owned coal miner, Solid Energy, but dodged journalists’ questions at his weekly press conference on whether that might prove necessary... More>>

ALSO:

Lagest Ever Privacy Breach Award: NZCU Baywide Accepts “Severe” Censure In Cake Case

NZCU Baywide says that once it was found to have committed a breach of a former staff member’s privacy, it had attempted to resolve the matter... the censure and remedies for its actions taken almost three years ago are “severe” but accepted, and will hopefully draw a line under the matter. More>>

ALSO:

Scoop Business: PayPal Stops Processing Mega Payments; NZX Listing Still On

PayPal has ceased processing payments for Mega, the file storage and encryption firm looking to join the New Zealand stock market via a reverse listing of TRS Investments, amid claims it is not a legitimate cloud storage service. More>>

ALSO:

Housing Policy: Auckland Densification As Popular As Ebola, English Says

Finance Minister Bill English said calls by the Reserve Bank Governor for more densification in Auckland’s housing were “about as popular in parts of Auckland as Ebola” would be. More>>

ALSO:

Get More From Scoop

 
 
Standards New Zealand

Standards New Zealand
 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news